Participants

As Europe's leading biopartnering and investment conference, BioTrinity brings together investors, pharmaceutical executives and innovative life sciences R&D companies under one roof, developing an industry community. Year on year the number and quality of participants is always impressive. 

The list of 2017 participating companies can be viewed below:

Participants

Red = Global Pharma/MedTech corporates
Green = Investors and financial service firms
Blue = Exhibitors

2bind GmbH (Germany)
Abbvie (United States)
AbbVie (United States)
Abgentis Ltd
Abingworth
Acousia Therapeutics GmbH (Germany)
Addex Therapeutics (Switzerland)
Advent Life Sciences
Aetas Global Markets (Hong Kong)
Agate Strategic Advisors
Agenus (United States)
Air Products
Akros Pharma Inc. (United States)
Alacrita
Albany Molecular Research Inc
Albion Technology & General VCT plc
Alderley Park Ventures
Alfacyte Ltd
Alta Innovations
Amal Therapeutics
Animalcare Limited
Antibiotic Research UK
Antikor Biopharma Ltd
apceth Biopharma GmbH (Germany)
Apex Healthcare Consulting Limited
Arcinova
Ardigen S.A. (Poland)
Arecor Ltd
Arix Bioscience
Atelix Ltd
Aurelia Bioscience
Auspherix
Avacta (United Kingdon)
Belive Concepts GmbH (Austria)
Benevolent Bio
BerGenBio (Norway)
BioAscent Discovery Ltd
BioCity Group
BioGeneration Ventures (Netherlands)
BioHub / BioCity
BioHub Birmingham
BiOrion Technologies (Netherlands)
Blueberry Therapeutics
Boehringer Ingelheim GmbH (Germany)
Boehringer Ingelheim GmbH (Germany)
Boehringer Ingelheim Venture Fund GmbH (Germany)
Boult Wade Tennant
Bristol-Myers Squibb (United States)
Brown Rudnick LLP
BTG plc
Business Birmingham
Caldan Therapeutics
Cambridge Consultants
Cambridge Healthcare & Biotech
Cambridge Innovation Capital
Cancer Research Technology
Cell Medica (United Kingdon)
Cello Health
Cellvax (France)
CHAIN Biotechnology
Charles River Laboratories
Chronos Therapeutics (United Kingdon)
Clinical Network Services (UK) Ltd
Clubb Capital Ltd
CN Bio Innovations
Communications Strategy Group Inc. (United States)
Confluence Tax
Coulter Partners
Covance Laboratories (Italy)
Crescendo Biologics Ltd
Cypralis Ltd
Daiichi Sankyo Europe GmbH (Germany)
Debiopharm International SA (CH)
Dementia Disovery Fund, SV
Department for International Trade (China)
Department for International Trade (China)
Diamond Biopharm
DJS Antibodies
Domain Therapeutics (France)
Domainex Ltd.
Draper Esprit
Droia NV (Belgium)
Drooms GmbH (Germany)
Dynasty Biotechnology & The Sino-UK Fund
EA Pharma Co., Ltd. (Japan)
EBD Group (Germany)
Eclosion/Netris pharma (Switzerland)
ecoplus.The Business Agency of Lower Austria (Austria)
Elasmogen Ltd (United Kingdon)
Eli Lilly and Company
Epidarex Capital
ESCO Ventures (Singapore)
Esperante
EURASANTE (France)
Exonate Ltd
EY
Eyevensys (France)
Flanders Investment and Trade
FlandersBio (Belgium)
Forbion Capital Partners (Netherlands)
Forendo Pharma Ltd (Finland)
Fountain Healthcare Partners (Ireland)
FreeMind Group (United States)
Galapagos NV (Belgium)
Galecto Biotech (Denmark)
Gemini Advisors (United States)
Genentech (United States)
george james Ltd
GHO Capital
Gilde Healthcare (Netherlands)
Gilde Healthcare Partners (Netherlands)
GSK
Harwell Science & Innovation Campus
HBM Partners (Switzerland)
HC Pharma Consultancy Ltd
Heptares Therapeutics Ltd
HGF Limited
HistologiX Ltd
Horizon Discovery
ICTA PM (France)
Image Analysis Group
Imanova Limited
Immodulon Therapeutics
Innova Biosciences
Innovate UK
InSphero AG (Switzerland)
InspiWave
Instinctif Partners
Institute of Food Research
InSymbiosis (Canada)
IP Group
Ipsen (France)
Ixchelsis Ltd
James Cowper Kreston
Johnson & Johnson
Joint Polish Investment Fund (Poland)
Jon Rees Associates Ltd
Julz Co (United States)
Junction Therapeutics (Ireland)
Leads To Development (France)
Leeds Beckett University
Life Sciences Hub Wales
LIFNano
LISAvienna (Austria)
Liverpool ChiroChem Ltd (United Kingdon)
Loki Steer Ltd (Ireland)
LSP (Netherlands)
Lundbeckfonden Ventures (Denmark)
Lycotec
Manentia
Mathys & Squire
Maven Capital Partners
Medicines Discovery Catapult
MediTox s.r.o. (Czech Republic)
MedTrace A/S (Denmark)
MEPC
Mercia Technologies
Merck Ventures (Netherlands)
Mereo BioPharma Group plc
Microbiotica
Midven
Milton Park
Mironid
MME (United States)
MRC Technology Ltd
MVM Life Science Partners LLP
Naked Ideas
Nanogenic Solutions
National Phenotypic Screening Centre - NPSC
NeoMed (Switzerland)
NeRRe Therapeutics
NeuroVive Pharmaceutical AB (Sweden)
New Wave Ventures
NIHR Clinical Research Network (University of Leeds)
Norgine Ventures Management Ltd
Northern Powerhouse
NorthWest EHealth
Novartis Venture Fund (Switzerland)
Novasecta
Novo A/S (Denmark)
Novotech (Australia)
O2h Ventures Limited
Oblita Therapeutics BVBA (Belgium)
OBN (UK) Ltd
Omnes Capital (France)
OrbiMed (Israel)
Osborne Clarke LLP
Osivax (France)
Oxford Academic Health Science Centre
Oxford Academic Health Science Network
Oxford Capital
Oxford Cardiomox
Oxford Endovascular Ltd
Oxford Sciences Innovation
Oxford Technology Management
Oxford University Innovation Ltd
Oxford Vacmedix Ltd
Oxfordshire Local Enterprise Partnership (LEP)
OxSonics Limited
Oxstem
PCI Clinical Services
PCI Pharma Services
PCR Biosystems
PDL BioPharma, Inc. (United States)
Penningtons Manches
PeptiGelDesign (United Kingdon)
Peptinnovate
Pfizer
PharmaCytics (Netherlands)
PharmaLex
Pharmalicensing
Pharmatory Ltd (Finland)
PhoreMost Ltd
Pinsent Masons LLP
Porsolt Sas (France)
PRECLIN Biosystems AG (Switzerland)
Premier Research
Private
Proximagen Limited
PsiOxus Therapeutics Limited
Public Health England
Queen Mary Innovation Ltd
QuickSTAT
Quotient Clinical
Rainbow Seed Fund
Re-Pharm
Redx Pharma Plc
Regulatory Resources Group
Results Healthcare
Rosetta Capital Ltd
Roundcape Ltd
Royal College of Surgeons in Ireland (Ireland)
Ryan-Kay Services
S-cubed
S-cubed Biometrics
S.R.One, Limited
Salzman Capital Ventures, Ltd. (Israel)
Sanifit (Spain)
Sareum
Science and Technology Facilities Council (STFC)
Selcia Ltd
Selvita S.A. (Poland)
Seroba Life Sciences (Ireland)
Sibelius (United Kingdon)
SmartAnalyst
SMS-oncology (Netherlands)
Sofinnova Partners (France)
SRG Synergy
Stabilitech Biopharma Ltd
StemTek Therapeutics (Spain)
Stevenage Bioscience Catalyst
Sunergos Innovations
SV Life Sciences
Sygnature Discovery
Syndicate Room
Takeda
Takeda R & D
The Association of the British Pharmaceutical Industry
The Oxford Science Park
Theradex
Tiber Creek Partners LLC (United States)
Tissue Solutions Ltd
Topivert Pharma Ltd
Touchstone Innovations
TranScrip
University of Nottingham
University of Oxford
V-Bio Ventures (Belgium)
Ventac Partners
Venture Valuation (Switzerland)
VHsquared Limited
Viramatix Sdn Bhd (Malaysia)
Voisin Consulting
Warwick Ventures Ltd
Wellington Partners (Germany)
Wessex AHSN & Wiltshire County Council
Wickham Laboratories Limited
Williamson Biotech Solutions
World Courier
Wren Capital
Ysios Capital (Spain)
Investors and Financial Services Firms
Abbvie (United States)
Advent Life Sciences
Aetas Global Markets (Hong Kong)
Agate Strategic Advisors
Albion Technology & General VCT plc
Alderley Park Ventures
Arix Bioscience
BioCity Group
BioHub / BioCity
Boehringer Ingelheim GmbH (Germany)
Boehringer Ingelheim Venture Fund GmbH (Germany)
Cambridge Innovation Capital
Clubb Capital Ltd
Dementia Disovery Fund, SV
Droia NV (Belgium)
Dynasty Biotechnology & The Sino-UK Fund
Epidarex Capital
ESCO Ventures (Singapore)
Esperante
Forbion Capital Partners (Netherlands)
Fountain Healthcare Partners (Ireland)
Gemini Advisors (United States)
GHO Capital
Gilde Healthcare (Netherlands)
HBM Partners (Switzerland)
IP Group
Johnson & Johnson
Joint Polish Investment Fund (Poland)
Jon Rees Associates Ltd
Julz Co (United States)
Loki Steer Ltd (Ireland)
LSP (Netherlands)
Lundbeckfonden Ventures (Denmark)
Maven Capital Partners
Mercia Technologies
Merck Ventures (Netherlands)
Midven
MVM Life Science Partners LLP
MVM Life Science Partners LLP
NeoMed (Switzerland)
New Wave Ventures
Norgine Ventures Management Ltd
Novartis Venture Fund (Switzerland)
Novo A/S (Denmark)
O2h Ventures Limited
Omnes Capital (France)
OrbiMed (Israel)
Oxford Capital
Oxford Sciences Innovation
Oxford Technology Management
Private
Rainbow Seed Fund
Rosetta Capital Ltd
Roundcape Ltd
S.R.One, Limited
Salzman Capital Ventures, Ltd. (Israel)
Seroba Life Sciences (Ireland)
Sofinnova Partners (France)
SV Life Sciences
Touchstone Innovations
V-Bio Ventures (Belgium)
Ventac Partners
Wellington Partners (Germany)
Ysios Capital (Spain)
Global Pharma
AbbVie - Senior Manager (United States)
AbbVie - Director, Search and Evaluation Oncology (United States)
AbbVie - Vice President, Corporate Strategy Office and Head, AbbVie Ventures (United States)
AbbVie - Senior Director, Business Development & Acquisitions (United States)
AbbVie - Director, Scientific Assessment, Licensing and Acquisitions (United States)
AbbVie - Sr. Director, AbbVie Ventures (United States)
AbbVie - Vice President, Search and Evaluation (United States)
AbbVie - VP Head of Business Development & Acquisitions (United States)
AbbVie - Sr. Director, AbbVie Ventures (United States)
AbbVie - Corporate Affairs and Policy Lead
AbbVie - VP & General Manager, UK
AbbVie Ltd - Director of Government Affairs
Boehringer Ingelheim GmbH - Vice President Boehringer Ingelheim Venture Fund (Germany)
Boehringer Ingelheim GmbH - Global Head of Oncology Business Development & Licensing (Germany)
Bristol-Myers Squibb - Director, Business Development Operations (United States)
Bristol-Myers Squibb - Director, Business Development (United States)
Bristol-Myers Squibb - Director, Mergers & Acquisitions (United States)
Bristol-Myers Squibb - VP, Head of Global Business Development (United States)
Bristol-Myers Squibb - Director, Search & Evaluation, Oncology, Business Development (United States)
Bristol-Myers Squibb - SVP, Head of Business Development (United States)
BTG plc - SVP Business Development
Daiichi Sankyo Europe GmbH - VP (Germany)
Daiichi Sankyo Europe GmbH - Director (Germany)
Eli Lilly and Company - Senior Director, Search & Evaluate - Neuroscience
Eli Lilly and Company - Sr. Vice President, Emerging Technology & Innovation (United States)
Eli Lilly and Company - Senior Director, External Innovation
Eli Lilly and Company - Vice President, Corporate Business Development (United States)
Genentech - Associate Director, Oncology Business Development (United States)
GSK - Director, Transactions, WWBD
GSK - Director, Immunology Innovation Fund
GSK - VP BD Head Immuno-Inflammation and Dermatology
Johnson & Johnson - Vice President Venture Investments
MSD - TBA
Pfizer - Senior Director
Takeda - TBA

2016 participants are listed here.